Minerva Neurosciences
NERV
20 hedge funds and large institutions have $16.6M invested in Minerva Neurosciences in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
5% more funds holding
Funds holding: 19 → 20 (+1)
7.85% less ownership
Funds ownership: 42.23% → 34.38% (-7.9%)
13% less capital invested
Capital invested by funds: $19M → $16.6M (-$2.46M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$627K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$96.8K |
| 3 |
Morgan Stanley
New York
|
+$41.3K |
| 4 |
State Street
Boston,
Massachusetts
|
+$25.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$13.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$192K |
| 2 |
BlackRock
New York
|
-$55.2K |
| 3 |
JP Morgan Chase
New York
|
-$40.4K |
| 4 |
Renaissance Technologies
New York
|
-$36.7K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$36.2K |
NERV Hedge Fund Activity: Q3 2023 in Review
20 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2023, worth a combined $16.6M — down 13% from $19M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NERV positions and 1 closed out — a net gain of 1 holder — while 6 added to existing stakes and 5 trimmed.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $627K. The largest seller was Virtu Financial, exiting entirely with an estimated $192K sold.
- 20 institutional investors held Minerva Neurosciences (NERV) as of Q3 2023, up from 19 in Q2 2023.
- Funds reported $16.6M of Minerva Neurosciences stock for Q3 2023, down 13% quarter-over-quarter.
- 2 funds opened new Minerva Neurosciences positions in Q3 2023 and 1 closed out, a net change of +1 holder.
- The largest Minerva Neurosciences buyer in Q3 2023 was UBS O'Connor, an estimated $627K added.
- The largest Minerva Neurosciences seller in Q3 2023 was Virtu Financial, an estimated $192K sold.
Based on aggregated 13F filings for Q3 2023.